Since ANGPTL4 expression reduces in obesity, use of probiotics for ANGPTL4 upregulation may be the main target of HFD-induced obesity prevention or treatment (Zandbergen et al., 2006). The gene discussed is ANGPTL4; the disease is obesity due to melanocortin 4 receptor deficiency.